Bicycle Therapeutics (BCYC) EBT (2018 - 2026)
Bicycle Therapeutics posted quarterly EBT of -$60.7 million for Q1 2026, up 1.92% year-on-year from -$59.5 million in Q1 2025, and down 137.51% on a QoQ basis from -$25.5 million in Q4 2025.
Bicycle Therapeutics (BCYC) has 9 years of EBT data on file, last reported at -$60.7 million in Q1 2026.
- For the quarter ending Q1 2026, EBT rose 1.92% year-over-year to -$60.7 million; the trailing twelve-month figure through Mar 2026 stood at -$224.3 million (down 670.31% YoY), and the FY2025 full-year result was -$225.5 million, down 3977.81% from the prior year.
- EBT for Q1 2026 stood at -$60.7 million, down from -$25.5 million in the prior quarter.
- Across five years, EBT topped out at $126.7 million in Q4 2024 and bottomed at -$79.2 million in Q2 2025.
- The 5-year median for EBT is -$39.7 million (2024), against an average of -$34.1 million.
- The widest annual swing landed in 2024, when EBT soared 341.05%; it then plunged 129.78% in 2025.
- A 5-year view of EBT shows it stood at -$32.4 million in 2022, then sank by 62.04% to -$52.6 million in 2023, then jumped by 341.05% to $126.7 million in 2024, then sank by 120.16% to -$25.5 million in 2025, then tumbled by 137.51% to -$60.7 million in 2026.
- The last three EBT figures came in at -$60.7 million (Q1 2026), -$25.5 million (Q4 2025), and -$58.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -2.99 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -19.60 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -15.31 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.25 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -3.18 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 831.20 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 221.65 Mn |
| 10 | Bicycle Therapeutics | 326.82 Mn | 326.82 Mn | - | -60.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -60.65 Mn |
| Dec 31, 2025 | -25.54 Mn |
| Sep 30, 2025 | -58.90 Mn |
| Jun 30, 2025 | -79.18 Mn |
| Mar 31, 2025 | -61.84 Mn |
| Dec 31, 2024 | 126.67 Mn |
| Sep 30, 2024 | -54.25 Mn |
| Jun 30, 2024 | -39.70 Mn |
| Mar 31, 2024 | -26.91 Mn |
| Dec 31, 2023 | -52.55 Mn |
| Sep 30, 2023 | -47.63 Mn |
| Jun 30, 2023 | -43.12 Mn |
| Mar 31, 2023 | -39.68 Mn |
| Dec 31, 2022 | -32.43 Mn |
| Sep 30, 2022 | -28.59 Mn |
| Jun 30, 2022 | -27.28 Mn |
| Mar 31, 2022 | -27.98 Mn |
| Dec 31, 2021 | -18.79 Mn |
| Sep 30, 2021 | -15.09 Mn |
| Jun 30, 2021 | -18.07 Mn |
| Mar 31, 2021 | -16.53 Mn |
| Dec 31, 2020 | -17.49 Mn |
| Sep 30, 2020 | -10.60 Mn |
| Jun 30, 2020 | -12.21 Mn |
| Mar 31, 2020 | -11.43 Mn |
| Dec 31, 2019 | -4.54 Mn |
| Sep 30, 2019 | -9.81 Mn |
| Jun 30, 2019 | -10.08 Mn |
| Mar 31, 2019 | -6.42 Mn |
| Dec 31, 2018 | -6.64 Mn |
| Sep 30, 2018 | -7.69 Mn |
| Jun 30, 2018 | -4.98 Mn |
| Mar 31, 2018 | -2.93 Mn |